Paclitaxel usually refers to paclitaxel injection. Pemetrexed usually refers to pemetrexed disodium for injection. It is impossible to single out which of these two drugs is more effective, and a comprehensive judgment is needed based on the condition.
Paclitaxel Injection is more suitable for neoadjuvant and adjuvant treatment of progressive ovarian cancer; adjuvant treatment of lymph node-positive breast cancer patients with adriamycin-containing standard regimen combined with chemotherapy as well as first-line treatment of non-small cell lung cancer patients.
Pemetrexed disodium for injection is often used in combination with cisplatin for the treatment of locally progressive or metastatic non-squamous cell carcinoma, first-line treatment of patients with non-small cell lung cancer; it can also be used in combination with cisplatin for the treatment of inoperable malignant pleural mesothelioma and other conditions.
It is usually impossible to judge which drug has better therapeutic effect. When using drug therapy, it must be combined with the physical disease and choose the appropriate drug therapy under the guidance of doctor, so as to achieve the ideal therapeutic effect.
Drug treatment must be carried out under the guidance of a doctor, do not self-medicate.